BellaSeno and Fraunhofer Institute for Production Technology IPT Receive EUR 1.4 Million BMBF Grant

Funding dedicated to the development of commercial-scale, fully automated additive manufacturing of resorbable medical implants First-ever industrial-scale, additive manufacturing platform of medical implants BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, and the Fraunhofer Institute for Production Technology IPT today announced that both parties have received a grant totaling Read more about BellaSeno and Fraunhofer Institute for Production Technology IPT Receive EUR 1.4 Million BMBF Grant[…]

Prototype-to-Production Assembly of Innovative Radiation Detection Products

Collaboration is one of the most important driving forces for continued growth in any business. Kromek, a leading developer of radiation detection products, has been able to meet its growth demand through an effective 20 years collaboration with Finetech and an assembly equipment pathway. Kromek is at the forefront of CZT (cadmium zinc telluride)-based radiation Read more about Prototype-to-Production Assembly of Innovative Radiation Detection Products[…]

Schärfere Augen für die Computertomographie: Metastasen besser beurteilen

Im Deutschen Krebsforschungszentrum (DKFZ) erproben Ärzte derzeit ein neuartiges Verfahren der Computertomographie (CT): Für die Darstellung von Knochenmetastasen bei fortgeschrittenen Brustkrebs-Erkrankungen verglichen DKFZ-Radiologen nun das neue "photonenzählende" CT mit der konventionellen CT-Bildgebung. Ihr Ergebnis: Mit der neuen Technik lassen sich deutlich feinere Strukturen darstellen, als es bisher möglich war. Brustkrebs bildet besonders häufig Absiedlungen in Read more about Schärfere Augen für die Computertomographie: Metastasen besser beurteilen[…]

BellaSeno Establishes GMP-Compliant High-Throughput Additive Manufacturing Facility for Resorbable Medical Implants

. – Seamless transition from R&D to commercial-scale additive manufacturing – Leading-edge cleanroom, no-touch manufacturing – GMP capabilities for internal and contract manufacturing BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced the establishment of a novel, leading-edge additive manufacturing facility for medical implants supported by the Fraunhofer Read more about BellaSeno Establishes GMP-Compliant High-Throughput Additive Manufacturing Facility for Resorbable Medical Implants[…]

Bayer erwirbt exklusive Lizenz von Systems Oncology für innovativen Behandlungsansatz ERSO™ bei Brustkrebs

Exklusive globale Lizenzvereinbarung zu präklinischem Wirkstoffkandidat ERSO™ zur Behandlung von metastasiertem Östrogenrezeptor-positiven Brustkrebs  Im Rahmen der Vereinbarung wird Bayer für die weltweite Entwicklung und Vermarktung von ERSO verantwortlich sein Bayer hat mit Systems Oncology, LLC, eine exklusive globale Lizenzvereinbarung für ERSO™ geschlossen, einem oral einzunehmenden Medikament in der präklinischen Entwicklung zur Behandlung von metastasiertem Östrogenrezeptor-positiven Read more about Bayer erwirbt exklusive Lizenz von Systems Oncology für innovativen Behandlungsansatz ERSO™ bei Brustkrebs[…]

BellaSeno Announces First-In-Human Trial of its Novel, Absorbable Soft Tissue Reconstruction Scaffold and Granting of Key U.S. Patent

First patient with Pectus Excavatum congenital defect has undergone surgery in Australia Minimally invasive procedure and fully absorbable scaffold expected to provide for improved safety and recovery Key U.S. patent granted for the design and porosity of Senella® platform BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced Read more about BellaSeno Announces First-In-Human Trial of its Novel, Absorbable Soft Tissue Reconstruction Scaffold and Granting of Key U.S. Patent[…]

Erste Spiral-Brust-CTs in zwei Praxen installiert

Das Erlanger Unternehmen AB-CT – Advanced Breast-CT hat sein neuartiges Spiral-Brust-CT nu:view zum ersten Mal in zwei radiologischen Praxen installiert. Das MVZ Prof. Dr. Uhlenbrock und Partner in Dortmund und DIE RADIOLOGEN in Regensburg vertrauen damit seit Kurzem der schonenden Hightech-Untersuchung. Sie bieten ihren Patientinnen eine kompressionslose Mammauntersuchung mit sehr hohem diagnostischem Potenzial, die in Read more about Erste Spiral-Brust-CTs in zwei Praxen installiert[…]

Covid-19 Pandemic and Issues for Cancer Patients

Cancer patients are a group at risk due to their illness. They now face additional problems due to the corona crisis: Cancer therapy is often associated with a weakening of the immunesystem. A weakening of the immunesystem is associated with a higher risk of infection, including a COVID-19 infection. This additional risk needs to be Read more about Covid-19 Pandemic and Issues for Cancer Patients[…]

Covid-19 Pandemic and Issues for Cancer Patients

Cancer patients are a group at risk due to their illness. They now face additional problems due to the corona crisis: Cancer therapy is often associated with a weakening of the immunesystem. A weakening of the immunesystem is associated with a higher risk of infection, including a COVID-19 infection. This additional risk needs to be Read more about Covid-19 Pandemic and Issues for Cancer Patients[…]

CSEM marks its 35th anniversary with an exceptional year

CSEM celebrated its 35th anniversary in 2019, chalking up a record increase in the number of research projects carried out by its scientists, while maintaining a high level of joint R&D projects with industry. These encouraging figures leave the Center well-positioned to face the challenges of the COVID-19 era. Going forward, CSEM plans to support Read more about CSEM marks its 35th anniversary with an exceptional year[…]